Power Law company profile

Nerio Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2019 Unicorn

Nerio is building a new generation of therapeutics targeting protein phosphatases for immunotherapy

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where Nerio Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · San Diego HQ

Book a demo for the full country breakdown

Patent intelligence

$161k patent portfolio · 8 active families

Estimated portfolio value

$161k

0.01% of valuation · 112.7× smaller than top peer PMV Pharmaceuticals ($18M)

8 active patent families

Where Nerio Therapeutics innovates CarcinosisMolecular biologyTyrosinePTPN1Cancer research

Where Nerio Therapeutics concentrates vs peers

Each axis is a top-10 topic across Nerio Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Nerio Therapeutics

An AI-synthesized read of the highest-engagement posts about Nerio Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nerio Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles